SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-20-012791
Filing Date
2020-03-25
Accepted
2020-03-25 15:22:31
Documents
93
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K apvo-10k_20191231.htm 10-K 2260941
2 EX-21.1 apvo-ex211_50.htm EX-21.1 6017
3 EX-23.1 apvo-ex231_51.htm EX-23.1 8890
4 EX-31.1 apvo-ex311_49.htm EX-31.1 19294
5 EX-31.2 apvo-ex312_52.htm EX-31.2 19521
6 EX-32.1 apvo-ex321_54.htm EX-32.1 10325
7 EX-32.2 apvo-ex322_53.htm EX-32.2 10432
8 GRAPHIC g2mzwu31cuci000001.jpg GRAPHIC 36885
  Complete submission text file 0001564590-20-012791.txt   8506550

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT apvo-20191231.xml EX-101.INS 1689473
10 XBRL TAXONOMY EXTENSION SCHEMA apvo-20191231.xsd EX-101.SCH 72706
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE apvo-20191231_cal.xml EX-101.CAL 65910
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE apvo-20191231_def.xml EX-101.DEF 232181
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE apvo-20191231_lab.xml EX-101.LAB 538989
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE apvo-20191231_pre.xml EX-101.PRE 428266
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37746 | Film No.: 20742041
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences